Skip to main content

Table 7 Overview of high-quality studies reporting relative statistical significance (vaccinees)

From: Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments

Category & domain (n=)*

Statistical significance**

P < 0.10

P < 0.05

P < 0.01

Total

Not significant

Outcome

 Protection duration (n = 6)

0

3

5

8

1

 Vaccine effectiveness (n = 8)

0

5

9

14

1

 Vaccine risk (n = 7)

0

4

11

15

0

Process

 Dosing & visits (n = 3)

1

1

3

5

1

 Time (n = 2)

0

0

0

0

2

 Vaccination age (n = 2)

0

1

2

2

1

 Vaccine accessibility (n = 1)

0

1

0

1

0

Cost

 Cost (n = 5)

0

1

8

9

0

Other

 Context (n = 1)

0

2

0

2

0

 Disease risk (n = 2)

0

1

2

3

0

 Information (n = 2)

1

1

3

5

0

 Other disease related factors (n = 1)

0

0

0

0

2

 Vaccine advice/support (n = 2)

1

0

4

5

0

  1. *n = number of studies reporting domains. All nine studies reported statistical significance; ** Information is based on main models and pooled data when available (if not, data of separate models/classes wasused). Some studies included more than one attribute related to a particular domain. Totals could hence exceed the total number of studies incorporated.